Article
Polymorphism of vascular endothelial growth factor -2578C/A with cancer risk: evidence from 11263 subjects.
Medical oncology (Northwood, London, England) - 1 Dec 2011
Cao Chao, Ying Tao, Fang Jing-Jing, Sun Shi-Fang, Lv Dan, Chen Zhong-Bo, Ma Hong-Ying, Yu Yi-Ming, Ding Qun-Li, Shu Li-Hua, Deng Zai-Chun
Abstract excerpt
Published data on the association between vascular endothelial growth factor (VEGF) -2578C/A polymorphism and cancer risk is inconclusive. To derive a more precise estimation of association between VEGF -2578C/A polymorphism and the risk of cancer, we performed a meta-analysis of 5415 cancer cases and 5848 controls from 16 published case-control studies. We used odds ratios (ORs) with 95% confidence intervals...
Topics
- Case-Control Studies
- Female
- Genetic Predisposition to Disease
- Humans
- Male
- Neoplasms
- Polymorphism, Single Nucleotide
- Risk Factors
- Vascular Endothelial Growth Factor A